Macromoltek designed a pool of virtual candidate antibodies to prevent COVID-19 from infiltrating cells and started tests for in vitro activity. The antibodies may be used as prophylactic to prevent front-line workers from being infected or to improve outcomes for those affected.

Macromoltek

Austin

Macromoltek startup from Austin, United States is ranked 1186 out of 2449 worldwide and 434 from the 748 startups in United States. See more information and additional rankings on the StartupBlink Global Ecosystem Map